Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Decrease of the postoperative inflammatory reaction during pars plana vitrectomy (PPV) after administration of

Anna Mańkowska1, Robert Rejdak, Agnieszka Oleszczuk

  • 1Katedra i Klinika Okulistyki Akademii Medycznej w Lublinie.

Klinika Oczna
|July 29, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tea tree oil action on human corneal epithelial cells biological activity.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Keratoconus molecular alterations revealed by Fourier-transform infrared spectroscopy.

Experimental eye research·2026
Same author

A deep learning approach for keratoconus detection using spatio-temporal features from corneal imaging.

Scientific reports·2026
Same author

Vascular Changes in the Macula and Peripapillary Regions Using Optical Coherence Tomography Angiography in Migraine with Aura and Migraine Without Aura.

Journal of clinical medicine·2026
Same author

Nanocarrier-Based Ocular Drug Delivery Systems for Retinal Diseases: Therapeutic Potential.

Life (Basel, Switzerland)·2026
Same author

Embryologic and fetal development of meibomian glands: Implications in aging and dry eye disease.

The ocular surface·2026

Triamcinolone acetonide (TA) injection during pars plana vitrectomy (PPV) significantly reduces postoperative inflammation and improves recovery. TA-assisted PPV demonstrates a lower breakdown of the blood-ocular barrier compared to standard PPV.

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Inflammation Research

Context:

  • Pars plana vitrectomy (PPV) is a common surgical procedure for various vitreoretinal diseases.
  • Postoperative inflammation and blood-ocular barrier disruption can impact patient recovery.
  • Triamcinolone acetonide (TA) is a corticosteroid with anti-inflammatory properties.

Purpose:

  • To prospectively evaluate the impact of intraoperative triamcinolone acetonide (TA) administration during pars plana vitrectomy (PPV).
  • To assess the effect of TA on postoperative inflammatory reactions and recovery.
  • To monitor the dynamics of blood-aqueous barrier disruption using laser flare photometry.

Summary:

  • Pars plana vitrectomy (PPV) was performed on 45 patients with TA injection and 15 patients without (control group).

Related Experiment Videos

  • Laser flare cell meter measurements indicated significantly lower tyndalometric values in the TA-treated group at 1 day, 10 days, and 6 weeks post-surgery.
  • The TA-assisted PPV group exhibited a significantly reduced breakdown of the blood-ocular barrier compared to the control group.

    • Impact:

    • Intraoperative TA administration effectively lowers postoperative inflammatory responses following PPV.
    • TA-assisted PPV facilitates improved and faster postoperative recovery.
    • This study highlights a potential adjunctive treatment to enhance outcomes in vitreoretinal surgery.